Michael Pisetsky, an officer at SI-BONE, Inc., has filed a notice to sell 29,665 shares of the company's common stock. This sale, valued at approximately $647,586, is part of a broader trend among executives in the surgical and medical instruments industry to manage their equity positions.

The filing, dated October 29, 2026, indicates that the shares to be sold were acquired through the vesting of restricted stock units from July 23, 2018, to October 1, 2025. This transaction is significant as it reflects the ongoing activity of company executives in the stock market, which can influence investor sentiment.

Background

SI-BONE, Inc. operates in the surgical and medical instruments sector, specifically focusing on innovative solutions for spinal surgery. The company, incorporated in Delaware, is publicly traded on NASDAQ under the ticker symbol SI-BONE. Recent filings show a pattern of stock transactions by Pisetsky, including a sale of 3,133 shares on October 2, 2026, and 3,725 shares on August 17, 2026.

What the Filing Says

The recent filing states, "The securities to be sold were acquired upon the vesting of restricted stock units during the period of 07/23/2018 through 10/01/2025." This indicates that Pisetsky is liquidating part of his equity stake in the company.

Impact

This move may affect various stakeholders, including investors and market analysts, who closely monitor executive transactions as indicators of confidence in the company's future. The surgical and medical instruments industry is competitive, and such sales can influence perceptions of company performance and stability.

What's Next

The filing does not say what happens next.